Skip to main content
. 2021 May 20;12:636175. doi: 10.3389/fendo.2021.636175

Figure 2.

Figure 2

A proposed model of diabetic kidney disease mediated by bile acids. Bile acids may inhibit endoplasmic reticulum stress, inflammation and fibrosis by activating FXR and TGR5 to improve diabetic kidney disease. BAs, bile acids; FXR, Farnesoid X receptor; TGR5, G protein-coupled receptor 5; ER stress, endoplasmic reticulum stress; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; ICAM-1, intercellular adhesion molecule-1; TGF-β1, transforming growth factor-β1; FN, fibronectin.